Kavitha Gnanasambandan, PhD

Presented a commercial growth strategy for Trader Joe's, a US-based grocery chain.

The Cornell Graduate Consulting Club (CGCC) and the NYU School of Medicine Consulting Club jointly organized a week-long management consulting case competition targeting non-MBA graduate students enrolled in top institutions across the North East.

As a marketing director of the 2015 Cornell-NYU Case competition:
- Designed marketing material including the team logo, event folders, and assisted with website design
- Brought in a silver and a bronze sponsors as part of our… Show more

The Cornell Graduate Consulting Club (CGCC) and the NYU School of Medicine Consulting Club jointly organized a week-long management consulting case competition targeting non-MBA graduate students enrolled in top institutions across the North East.

As a marketing director of the 2015 Cornell-NYU Case competition:
- Designed marketing material including the team logo, event folders, and assisted with website design
- Brought in a silver and a bronze sponsors as part of our fundraising campaign
- Provided suggestions as a team member in preparing the event budget, fundraising and case preparation Show less

- We created a life cycle strategic plan for Remicade® as a part of the 'Drug Discovery, Development and Commercialization' on Coursera (organized by Dr. Williams Ettouati, UCSD).
- I contributed constructively as an active team player and co-ordinated a multidisciplinary team across 2 continents and 4 countries.
- I particularly covered the clinical strategy for Remicade® and identified that the strong post-marketing clinical data acquired by JNJ and its partners over the years could… Show more

- We created a life cycle strategic plan for Remicade® as a part of the 'Drug Discovery, Development and Commercialization' on Coursera (organized by Dr. Williams Ettouati, UCSD).
- I contributed constructively as an active team player and co-ordinated a multidisciplinary team across 2 continents and 4 countries.
- I particularly covered the clinical strategy for Remicade® and identified that the strong post-marketing clinical data acquired by JNJ and its partners over the years could provide a competitive advantage over the biosimilars.
- Together, we developed alternative sales, marketing, and IP strategies that could be adopted by JNJ to protect the eroding sales of Remicade®, in light of the biosimilars launch.

Show less